Crossmark

A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from Tridax procumbens as anticancer drug by in-silico approach

Crossref DOI link: https://doi.org/10.1007/s11224-022-01882-7

Published Online: 2022-01-28

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lakhera, Shradha

Rana, Meenakshi

Devlal, Kamal

Celik, Ismail

Yadav, Rohitash
License Information

Text and Data Mining valid from 2022-01-28

Version of Record valid from 2022-01-28
More Information

Article History

Received: 22 October 2021

Accepted: 13 January 2022

First Online: 28 January 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below